|
Volumn 51, Issue 1, 2009, Pages 108-110
|
Uptake of male circumcision in an hiv vaccine efficacy trial
a a,b a a a c c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GAG PROTEIN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
HVTN 503;
NEF PROTEIN;
POL PROTEIN;
UNCLASSIFIED DRUG;
AFRICA;
CIRCUMCISION;
CLINICAL TRIAL;
HETEROSEXUALITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
LETTER;
PRIORITY JOURNAL;
VIRUS TRANSMISSION;
ADOLESCENT;
ADULT;
AIDS VACCINES;
CIRCUMCISION, MALE;
HIV INFECTIONS;
HUMANS;
MALE;
RISK-TAKING;
SEXUAL BEHAVIOR;
SOUTH AFRICA;
YOUNG ADULT;
|
EID: 67651162301
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/QAI.0b013e3181a03622 Document Type: Letter |
Times cited : (10)
|
References (6)
|